Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancer

Gynecologic Oncology

Volumn 111, Issue 3, 2008, Pages 444-448

  Bae, Jeong Hoon ^a   Lee, Sung Jong ^a   Lee, Ahwon ^a   Park, Yong Gyu ^a   Bae, Seog Nyeon ^a   Park, Jong Sup ^a   Namkoong, Sung Eun ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Cervical cancer; Cisplatin; Etoposide; Neoadjuvant chemotherapy

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; FEMALE; HUMAN; LEUKOPENIA; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; SENSORY NEUROPATHY; THROMBOCYTOPENIA; UTERINE CERVIX CANCER;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 56449098398     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.07.034     Document Type: Article

References (24)

1. Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer 39 (2003) 2470-2486
2. Alberts D.S., Garcia D., and Mason-Liddil N. Cisplatin in advanced cancer of the cervix: an update. Semin. Oncol 18 (1991) 11-24
3. Benedetti-Panici P., Greggi S., Colombo A., Amoroso M., Smaniotto D., Giannarelli D., et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol 20 (2002) 179-188
4. Lee S.B., Tong S.Y., Kim J.J., Um S.J., and Park J.S. Caspase-independent autophagic cytotoxicity in etoposide-treated CaSki cervical carcinoma cells. DNA Cell Biol 26 (2007) 713-720
5. Al-Saleh E., Hoskins P.J., Pike J.A., and Swenerton K.D. Cisplatin/etoposide chemotherapy for recurrent or primarily advanced cervical carcinoma. Gynecol Oncol 64 (1997) 468-472
6. Sundstrøm S., Bremnes R.M., Kaasa S., Aasebø U., Hatlevoll R., Dahle R., et al. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up. J Clin Oncol 20 (2002) 4665-4672
7. Meyer T., Nelstrop A.E., Mahmoudi M., and Rustin G.J. Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer. Ann Oncol 12 (2001) 1705-1709
8. National Cancer Institute. Common Toxicity Criteria (CTC) (Version 2), published April 30, 1999. (http://ctep.cancer.gov/forms/CTCv20_4-30-992.pdf).
9. World Health Organization: WHO handbook for reporting results of cancer treatment. WHO offset publication No. 48. Geneva, Switzerland, WHO, 1979. Out-of-print publication: http://whqlibdoc.who.int/publications/9241700483.pdf .
10. Namkoong S.E., Park J.S., Kim J.W., Bae S.N., Han G.T., Lee J.M., et al. Comparative study of the patients with locally advanced stages I and II cervical cancer treated by radical surgery with and without preoperative adjuvant chemotherapy. Gynecol Oncol 59 (1995) 136-142
11. Delgado G., Bundy B., Zaino R., Sevin B.U., Creasman W.T., and Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 38 (1990) 352-357
12. Roman L.D., Felix J.C., Muderspach L.I., Varkey T., Burnett A.F., Qian D., et al. Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix. Gynecol Oncol 68 (1998) 220-225
13. Whitney C.W., Sause W., Bundy B.N., Malfetano J.H., Hannigan E.V., Fowler Jr. W.C., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17 (1999) 1339-1348
14. Morris M., Eifel P.J., Lu J., Grigsby P.W., Levenback C., Stevens R.E., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340 (1999) 1137-1143
15. Keys H.M., Bundy B.N., Stehman F.B., Muderspach L.I., Chafe W.E., Suggs III C.L., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340 (1999) 1154-1161
16. Peters III W.A., Liu P.Y., Barrett II R.J., Stock R.J., Monk B.J., Berek J.S., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613
17. Gozuacik D., and Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23 (2004) 2891-2906
18. Sardi J., Sananes C., Giaroli A., Bayo J., Rueda N.G., Vighi S., et al. Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of the cervix. Gynecol Oncol 49 (1993) 156-165
19. Leone B., Vallejo C., Perez J., Cuevas M.A., Machiavelli M., Lacava J., et al. Ifosfamide and cisplatin as neoadjuvant chemotherapy for advanced cervical carcinoma. Am J Clin Oncol 19 (1996) 132-135
20. Weiner S.A., Aristizabal S., Alberts D.S., Surwit E.A., and Deatherage-Deuser K. A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma. Gynecol Oncol 30 (1988) 1-6
21. Vallejo C.T., Pérez J.E., Domínguez M.E., Leone B.A., Machiavelli M.R., Lacava J.A., et al. Neoadjuvant chemotherapy with ifosfamide, cisplatin, and vinorelbine in advanced squamous cell carcinoma of the cervix. Am J Clin Oncol 23 (2000) 481-486
22. Aoki Y., Tomita M., Sato T., Watanabe M., Kase H., Fujita K., et al. Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix. Gynecol Oncol 83 (2001) 263-267
23. Huang H.J., Chang T.C., Hong J.H., Tseng C.J., Chou H.H., Huang K.G., et al. Prognostic value of age and histologic type in neoadjuvant chemotherapy plus radical surgery for bulky (>/=4 cm) stage IB and IIA cervical carcinoma. Int J Gynecol Cancer 13 (2003) 204-211
24. Singh K.C., Agarwal A., Agarwal S., Rajaram S., Goel N., and Agarwal N. 'Quick course' neoadjuvant chemotherapy with cisplatin, bleomycin and vincristine in advanced cervical cancer. Gynecol Obstet Invest 58 (2004) 109-113